Doctor profile · Federal record
Dr. Felipe Batalini Freitas Silva, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Scottsdale, AZ
- NPI 1306230867
- Accepts Medicare
- MIPS 78.6 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
13400 E Shea Blvd
Scottsdale, AZ 852595499
(480) 301-8000 - Additional location
-
725 Albany St, Shapiro 5 & 6
Boston, MA 021182526
(617) 414-5951
fax (617) 414-9251
Credentials & registration
- NPI registered
- March 2015 — 11 yrs on file
- Profile last updated
- September 10, 2021
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #63987
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306230867. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
30,115
Distinct HCPCS
10
Medicare allowed
$845,091
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 6,600 | 24 | $53 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,400 | 26 | $48 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,800 | 28 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 3,396 | 18 | $0 | |
J9025 |
Injection, azacitidine, 1 mg | 2,000 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,980 | 21 | $23 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,010 | 12 | $27 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 920 | 16 | $45 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 920 | 81 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 750 | 62 | $0 |
In context: peer comparison
Among 28 peers in this city , average services per provider: 963. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$10,507
Transactions
15
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 12 | $7,282.69 | |
| AstraZeneca Pharmaceuticals LP | 3 | $3,224.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
165
Patients
61
Total drug cost
$3,619
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 59 | 26 | $1,824 |
| Ondansetron Hcl | Generic | 25 | 18 | $415 |
| Dexamethasone | Generic | 21 | 0 | $128 |
| Prochlorperazine Maleate | Generic | 21 | 17 | $282 |
| Anastrozole | Generic | 20 | 0 | $320 |
| Tamoxifen Citrate | Generic | 19 | 0 | $652 |
Hospital affiliations
Frequently asked questions
What is Dr. Felipe Batalini Freitas Silva's medical specialty?
Dr. Felipe Batalini Freitas Silva practices Hematology & Oncology Physician in Scottsdale, AZ.
Where does Dr. Felipe Batalini Freitas Silva practice?
Dr. Felipe Batalini Freitas Silva practices at 13400 E Shea Blvd, Scottsdale, AZ 852595499. Office phone: 4803018000.
What is Dr. Felipe Batalini Freitas Silva's NPI?
Dr. Felipe Batalini Freitas Silva's National Provider Identifier (NPI) is 1306230867, issued by NPPES.
Does Dr. Felipe Batalini Freitas Silva accept Medicare assignment?
Yes. Dr. Felipe Batalini Freitas Silva accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Felipe Batalini Freitas Silva commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.